Assessment of Structural Intolerance and Durability
General Structure Information 2v9y GART human aminoimidazole ribonucleotide synthetase 2.1Å AUTH M.WELIN,J.G.GROSSMANN,S.FLODIN,T.NYMAN,P.STENMARK,AUTH 2 L.TRESAUGUES,T.KOTENYOVA,I.JOHANSSON,P.NORDLUND,L.LEHTIOTITL STRUCTURAL STUDIES OF TRI-FUNCTIONAL HUMAN GART.REF NUCLEIC ACIDS RES. V. 38 7308 2010REFN ISSN 0305-1048PMID 20631005DOI 10.1093/NAR/GKQ595 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped Variants
General Structure Information 3kex ERBB3 crystal structure of the catalytically inactive kinase domain of the human epidermal growth factor receptor 3 (her3) 2.8Å AUTH N.JURA,Y.SHAN,X.CAO,D.E.SHAW,J.KURIYANTITL STRUCTURAL ANALYSIS OF THE CATALYTICALLY INACTIVETITL 2 KINASE DOMAIN OF THE HUMAN EGF RECEPTOR 3.REF PROC.NATL.ACAD.SCI.USA V. 106 21608 2009REFN ISSN 0027-8424PMID 20007378DOI 10.1073/PNAS.0912101106 Variant Set Distributions Ripley’s K Analysis […]
General Structure Information 3hnc RRM1 crystal structure of human ribonucleotide reductase 1 bound to the effector ttp 2.41Å AUTH J.W.FAIRMAN,S.R.WIJERATHNA,M.F.AHMAD,H.XU,R.NAKANO,S.JHA,AUTH 2 J.PRENDERGAST,R.M.WELIN,S.FLODIN,A.ROOS,P.NORDLUND,Z.LI,AUTH 3 T.WALZ,C.G.DEALWISTITL STRUCTURAL BASIS FOR ALLOSTERIC REGULATION OF HUMANTITL 2 RIBONUCLEOTIDE REDUCTASE BY NUCLEOTIDE-INDUCEDTITL 3 OLIGOMERIZATION.REF NAT.STRUCT.MOL.BIOL. V. 18 316 2011REFN ISSN 1545-9993PMID 21336276DOI 10.1038/NSMB.2007 Variant Set Distributions Ripley’s K Analysis Plots Variant […]
General Structure Information 3hei EFNA1 ligand recognition by a-class eph receptors: crystal structures of the epha2 ligand-binding domain and the epha2/ephrin-a1 complex 2.0Å AUTH J.P.HIMANEN,Y.GOLDGUR,H.MIAO,E.MYSHKIN,H.GUO,M.BUCK,AUTH 2 M.NGUYEN,K.R.RAJASHANKAR,B.WANG,D.B.NIKOLOVTITL LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTALTITL 2 STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THETITL 3 EPHA2/EPHRIN-A1 COMPLEX.REF EMBO REP. V. 10 722 2009REFN ISSN 1469-221XPMID 19525919DOI […]
General Structure Information 3bi6 WEE1 wee1 kinase complex with inhibitor pd352396 2.2Å AUTH J.B.SMAILL,H.H.LEE,B.D.PALMER,A.M.THOMPSON,AUTH 2 C.J.SQUIRE,E.N.BAKER,R.J.BOOTH,A.KRAKER,K.HOOK,AUTH 3 W.A.DENNYTITL SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OFTITL 2 SOLUBLE 8-SUBSTITUTEDTITL 3 4-(2-CHLOROPHENYL)-9-HYDROXYPYRROLO[3,4-TITL 4 C]CARBAZOLE-1,3(2H,6H)-DIONES AS INHIBITORS OF THETITL 5 WEE1 AND CHK1 CHECKPOINT KINASES.REF BIOORG.MED.CHEM.LETT. V. 18 929 2008REFN ISSN 0960-894XPMID 18191399DOI 10.1016/J.BMCL.2007.12.046 Variant Set Distributions Ripley’s K Analysis […]
General Structure Information 3kka EPHA1 co-crystal structure of the sam domains of epha1 and epha2 2.4Å AUTH J.R.WALKER,L.YERMEKBAYEVA,C.BUTLER-COLE,J.WEIGELT,AUTH 2 C.BOUNTRA,C.H.ARROWSMITH,A.M.EDWARDS,A.BOCHKAREV,AUTH 3 S.DHE-PAGANONTITL CO-CRYSTAL STRUCTURE OF THE SAM DOMAINS OF HUMANTITL 2 EPHRIN TYPE-A RECEPTOR 1 AND HUMAN EPHRIN TYPE-ATITL 3 RECEPTOR 2REF TO BE PUBLISHEDREFN Variant Set Distributions Mapped Variants
General Structure Information 3bbb NME2 crystal structure of the nm23-h2 transcription factor complex with dinucleotide d(ag) 1.3Å AUTH T.S.DEXHEIMER,S.S.CAREY,S.ZUOHE,V.M.GOKHALE,X.HU,L.B.MURATA,AUTH 2 E.M.MAES,A.WEICHSEL,D.SUN,E.J.MEUILLET,W.R.MONTFORT,AUTH 3 L.H.HURLEYTITL NM23-H2 MAY PLAY AN INDIRECT ROLE IN TRANSCRIPTIONALTITL 2 ACTIVATION OF C-MYC GENE EXPRESSION BUT DOES NOT CLEAVE THETITL 3 NUCLEASE HYPERSENSITIVE ELEMENT III1.REF MOL.CANCER THER. V. 8 1363 2009REFN ISSN 1535-7163PMID […]
General Structure Information 2k1l EPHA1 nmr structures of dimeric transmembrane domain of the receptor tyrosine kinase epha1 in lipid bicelles at ph 6.3 -1.0Å AUTH E.V.BOCHAROV,M.L.MAYZEL,P.E.VOLYNSKY,M.V.GONCHARUK,AUTH 2 Y.S.ERMOLYUK,A.A.SCHULGA,E.O.ARTEMENKO,R.G.EFREMOV,AUTH 3 A.S.ARSENIEVTITL SPATIAL STRUCTURE AND PH-DEPENDENT CONFORMATIONALTITL 2 DIVERSITY OF DIMERIC TRANSMEMBRANE DOMAIN OF THETITL 3 RECEPTOR TYROSINE KINASE EPHA1.REF J.BIOL.CHEM. V. 283 29385 2008REFN ISSN 0021-9258PMID […]
General Structure Information 3ipy DCK x-ray structure of human deoxycytidine kinase in complex with an inhibitor 2.54Å AUTH T.C.JESSOP,J.E.TARVER,M.CARLSEN,A.XU,J.P.HEALY,AUTH 2 A.HEIM-RIETHER,Q.FU,J.A.TAYLOR,D.J.AUGERI,M.SHEN,T.R.STOUCH,AUTH 3 R.V.SWANSON,L.W.TARI,M.HUNTER,I.HOFFMAN,P.E.KEYES,X.C.YU,AUTH 4 M.MIRANDA,Q.LIU,J.C.SWAFFIELD,S.DAVID KIMBALL,A.NOURALDEEN,AUTH 5 A.G.WILSON,A.M.FOUSHEE,K.JHAVER,R.FINCH,S.ANDERSON,AUTH 6 T.ORAVECZ,K.G.CARSONTITL LEAD OPTIMIZATION AND STRUCTURE-BASED DESIGN OF POTENT ANDTITL 2 BIOAVAILABLE DEOXYCYTIDINE KINASE INHIBITORS.REF BIOORG.MED.CHEM.LETT. V. 19 6784 2009REFN ISSN 0960-894XPMID 19836232DOI 10.1016/J.BMCL.2009.09.081 Variant Set Distributions […]
General Structure Information 2qon EPHA3 human epha3 kinase and juxtamembrane region, y596f:y602f:y742a triple mutant 1.79Å AUTH T.L.DAVIS,J.R.WALKER,P.LOPPNAU,C.BUTLER-COLE,AUTH 2 A.ALLALI-HASSANI,S.DHE-PAGANONTITL AUTOREGULATION BY THE JUXTAMEMBRANE REGION OF THE HUMANTITL 2 EPHRIN RECEPTOR TYROSINE KINASE A3 (EPHA3).REF STRUCTURE V. 16 873 2008REFN ISSN 0969-2126PMID 18547520DOI 10.1016/J.STR.2008.03.008 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity […]